40% boost in survival for men: Pairing two cancer drugs may reduce prostate cancer death risk

A groundbreaking study reveals that combining two drugs significantly boosts survival for men with high-risk, recurring prostate cancer. This dual therapy, now readily available in India, effectively ‘starves’ the disease by suppressing testosterone. Early detection through screening and risk assessment remain crucial, complemented by healthy lifestyle choices for optimal outcomes.